Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases

Erlotinib and pemetrexed have been approved for the second-line treatment of non-small cell lung cancer. Recent reports indicated that erlotinib and pemetrexed exerted synergistic effects against lung adenocarcinoma. The available treatment options for lung cancer with brain metastases (BM) are curr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: ZHANG, YALEI, YANG, HAIHONG, YANG, XINYUN, DENG, QIUHUA, ZHAO, MEILIN, XU, XIN, HE, JIANXING
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3999131/
https://ncbi.nlm.nih.gov/pubmed/24772316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados